20 March 2023
SHARE NOW
Cell Therapy
Gene Therapy
Logistics
Regulatory & Standards
Supply Chain
Viral/Non-Viral Vectors
Maggie Chen, Head of Manufacturing at AGC Biologics, explores the challenges within the cell and gene therapy landscape.
In this interview, Maggie initially considers challenges associated with the cost of goods and supply chain, before discussing how standardization will benefit viral vector development.
Maggie goes on to address analytics and bad data as rate limiting factors to the progression of the field, and how a combination of different approaches may be what’s needed to realize the future of cell and gene therapies, before explaining what we might have to look forward to from AGC Biologics.
This interview has been produced in partnership with AGC Biologics and was recorded at Advanced Therapies Week 2023.
 |
 |
More like this
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a cost-effective, high-productivity extracellular vesicle (EV) production platform that overcomes traditional manufacturing challenges? Join us to discover how Univercells Technologies’ scalable fixed-bed design is transforming EV manufacturing.
14 May 2024
Women in Advanced Therapies Global 2024, Virtual Event
Experience Women in Advanced Therapies Global, a 24-hour online event uniting the community in celebration of inspiration, innovation, and empowerment. Access exclusive insights, workshops, and networking opportunities from anywhere.
8 April 2024
